Central venous access device-related upper extremity deep vein thrombosis

From IDWiki

Revision as of 14:11, 19 September 2025 by Aidan (talk | contribs) (Created page with " == Management == * Anticoagulation * If CVAD still needed: continue anticoagulation while it is in situ * If CVAD no longer needed: ** If it can be left in situ, leave it for up to 3-5 days, up to 7 days, while on anticoagulation to reduce risk of embolism ** Continue anticoagulation for 3 months * Choice of anticoagulation is primarily LMWH == Prevention == * Use small calibre catheter possible * Ensure proper catheter tip location * Remove CVADs when no longer...")

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to:navigation, search

Management

Anticoagulation
If CVAD still needed: continue anticoagulation while it is in situ
If CVAD no longer needed:
- If it can be left in situ, leave it for up to 3-5 days, up to 7 days, while on anticoagulation to reduce risk of embolism
- Continue anticoagulation for 3 months
Choice of anticoagulation is primarily LMWH

Prevention

Use small calibre catheter possible
Ensure proper catheter tip location
Remove CVADs when no longer needed
No benefit to prophylactic anticoagulation

Further Reading

How I treat central venous access device–related upper extremity deep vein thrombosis. Blood 2017;129(20):2727–2736. doi: 10.1182/blood-2016-08-693671

Retrieved from "https://idwiki.org/index.php?title=Central_venous_access_device-related_upper_extremity_deep_vein_thrombosis&oldid=11278"